In another study, researchers made genetically engineered breast cancer cell-derived exosomes that overexpress α-lactalbumin (α-LA) and loaded them with immunogenic cell death (ICD) inducers, ELANE (catalytically active neutrophil elastase) and Hiltonol (TLR3 agonist), simultaneously. The gene discussed is ELANE; the disease is breast carcinoma.